09/15/2026
📢 Exciting news: AstraZeneca's Etcamah is officially FDA approved for adults with HR-positive, HER2-negative advanced breast cancer with an emerging ESR1 mutation during first-line therapy.
Need branded materials? Contact us today → https://hubs.ly/Q04xyCpg0